Zobrazeno 1 - 10
of 815
pro vyhledávání: '"high-risk prostate cancer."'
Publikováno v:
BJUI Compass, Vol 5, Iss 11, Pp 1034-1043 (2024)
Abstract No pan‐India‐specific guidelines exist for the management of urological cancers. Although western guidelines are useful for informing management strategies, they do not account for the nuances of management in the Indian context. A modif
Externí odkaz:
https://doaj.org/article/56a9aac4bc814051962b034d6fa937d6
Autor:
Daimantas Milonas, Alexander Giesen, Tim Muilwijk, Charlotte Soenens, Gaëtan Devos, Zilvinas Venclovas, Alberto Briganti, Paolo Gontero, R. Jeffrey Karnes, Piotr Chlosta, Frank Claessens, Gert De Meerleer, Wouter Everaerts, Markus Graefen, Giansilvio Marchioro, Rafael Sanchez-Salas, Bertrand Tombal, Henk Van Der Poel, Hendrik Van Poppel, Martin Spahn, Steven Joniau
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 33-37 (2024)
International Society of Urological Pathology grade group 1 (GG 1) prostate cancer (PCa) is generally considered insignificant, with recent suggestions that it should even be considered as “noncancerous”. We evaluated outcomes for patients with G
Externí odkaz:
https://doaj.org/article/c8d0ad4edb444a3cbd022eb478d1fc4d
Autor:
Rachel M. Glicksman, Andrew Loblaw, Gerard Morton, Danny Vesprini, Ewa Szumacher, Hans T. Chung, William Chu, Stanley K. Liu, Chia-Lin Tseng, Melanie Davidson, Andrea Deabreu, Alexandre Mamedov, Liying Zhang, Patrick Cheung
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 49, Iss , Pp 100843- (2024)
Background and purpose: Data is needed regarding the use of ultrahypofractionated radiotherapy (UHRT) in the context of prostate cancer elective nodal irradiation (ENI), and how this compares to conventionally fractionated radiotherapy (CFRT) ENI wit
Externí odkaz:
https://doaj.org/article/51b8d796a410414e9346719ea6b1cc28
Autor:
Almudena Zapatero, Pablo Castro, María Roch, Pablo Rodríguez Carnero, Sara Carroceda, Alexandra Elena Stoica Rosciupchin, Sergio Honorato Hernández, Leopoldo Cogorno, Alfonso Gómez Iturriaga, David Büchser García
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Stereotactic ablative body radiotherapy (SABR) is an emerging treatment alternative for patients with localized low and intermediate risk prostate cancer patients. As already explored by some authors in the context of conventional
Externí odkaz:
https://doaj.org/article/c340109435924554bc9fb0ab47537450
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-8 (2024)
Abstract Background Prostate cancer is the second most common malignancy in men, and its incidence is increasing which is attributed to increased screening programs. The treatment options of intermediate and high risk prostate cancer include radical
Externí odkaz:
https://doaj.org/article/828cc835b2ab4baa9ec664ce5631d14f
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 12, Pp 1204-1214 (2023)
The incidence rate of prostate cancer is showing an upward trend year by year, gradually becoming an important disease affecting the health of middle-aged and elderly men. The high-risk prostate cancer is a type of prostate cancer with at least one h
Externí odkaz:
https://doaj.org/article/f712cc2b3a0146b6a3f79fc5ec159d8a
Publikováno v:
Research and Reports in Urology, Vol Volume 15, Pp 541-552 (2023)
Simone Ferretti,1 Paolo Dell’Oglio,2– 4 Davide Ciavarella,1 Antonio Galfano,2 Luigi Schips,1 Michele Marchioni1 1Department of Medical, Oral and Biotechnological Sciences, G. d’Annunzio University of Chieti, Urology Unit, Chieti, Italy; 2Depart
Externí odkaz:
https://doaj.org/article/651719ebebcc442694942568323ff546
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Background Prostate cancer (PC) is the most common cancer in older men in Europe and the United States and has the second highest death rate among male cancers. The transcription of heat shock proteins by Heat shock factor 1 (HSF1) is known
Externí odkaz:
https://doaj.org/article/e8237d3be0c547be8c3972c29b0897f5
Autor:
Ashley Li Kuan Ong, Kellie Knight, Vanessa Panettieri, Mathew Dimmock, Jeffrey Kit Loong Tuan, Hong Qi Tan, Caroline Wright
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Background and purposeThis study aimed to investigate the feasibility of safe-dose escalation to dominant intraprostatic lesions (DILs) and assess the clinical impact using dose-volume (DV) and biological metrics in photon and proton therapy. Biologi
Externí odkaz:
https://doaj.org/article/f79df9bc3ca24efd8b2ff553b5aafb6b
Autor:
Irina Vierasu, Gaetan Van Simaeys, Nicola Trotta, Simon Lacroix, Guy Bormans, Simone Albisinni, Thierry Quackels, Thierry Roumeguère, Serge Goldman
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Background Positron emission tomography/computed tomography (PET/CT) using radiotracers that bind to the prostate-specific membrane antigen (PSMA) is mainly used in biochemical recurring prostate cancer. The aim of our study was to assess th
Externí odkaz:
https://doaj.org/article/60eb4b0b2cc54313baf95b851d7f2cfc